We are thrilled to share that the ALS TDI lab has officially moved to our new location in Watertown, MA. This new state-of-the-art 16,000 square foot space has been customized to accommodate our comprehensive approach to ALS research. Here are of some of the highlights of the new lab space:

  • A central collaborative lab space where our multidisciplinary science team shares resources and equipment.
  • Multiple cell culture suites to serve both discovery biology efforts and induced pluripotent stem cell (iPSC) phenotype discovery.
  • A large state-of-the-art animal care facility – this time designed to support both rodents and zebrafish models of ALS. We will continue to broaden this animal facility to support our expanding in-vivo models.
  • A dedicated microscopy suite to delve into the molecular, cellular, and anatomical hallmarks of ALS.
  • A translational research wing housing the Augie’s Quest Translational Research Center and essential equipment for automated drug screening.

Together with office suites dedicated to collecting and analyzing ALS patient data, these facilities are all designed to foster efficiency and collaboration. In this space, under one roof, our preclinical, clinical, and translational research teams will continue to work relentlessly to end ALS.

And, of course, the new lab will once again be adorned with photos and mementos from supporters and community members who are united in ALS TDI’s mission to end ALS. You serve as a constant reminder of who we are working for and why our research needs to continue.

Thank you for providing the support that has allowed us to continue to expand our programs and to build out this new space. This is your lab, and we will not stop until we have treatments for every single person living with this disease.

With you in mind, the entire science team is poised to hit the ground running in our new location. When it’s safe, we look forward to welcoming you, the ALS community, to our new home, and your new lab.